Trial Information
A Multi-centre, Naturalistic Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of EGFR TKI in Male Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer of Adeno Histology Failed 1st Line Chemotherapy
Inclusion Criteria:
- Male patients age 20 years or older
- Histological or cytological confirmation of NSCLC of adeno histology. If sputum is
the only available sample, a second positive test is necessary for cytological
confirmation
- Locally advanced or metastatic on or after first-line chemotherapy. Imaging evidence
of disease progression can be either chest X ray, CT or MRI assessment on measurable
lesions. If no measurable lesion is available, evaluable lesions are acceptable
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Correlation between smoking patterns and best objective tumor response rate
Outcome Time Frame:
6 Months
Safety Issue:
No
Principal Investigator
Chun-Ming Tsai, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Taipei Ventrans General Hospital
Authority:
Taiwan: Institutional Review Board
Study ID:
NIS-OTW-IRE-2009/1
NCT ID:
NCT00922025
Start Date:
August 2009
Completion Date:
December 2010
Related Keywords:
- Non Small Cell Lung Cancer
- NSCLC
- Male
- Smoking Pattern
- Efficacy
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Smoking